Cardinal Health Analysts Increase Their Forecasts Following Q4 Results

Cardinal Health, Inc (NYSE:CAH) on Tuesday posted mixed results for the fourth quarter.

Benzinga • 18 hours ago

CAH Q4 Earnings Call Centers on Fiscal 2027 Growth Outlook

Cardinal Health targets 13%-15% fiscal 2027 EPS growth as pharma demand normalizes and specialty, At-Home and buybacks remain key priorities for execution.

Zacks Investment Research • 16 hours ago

Cardinal Health forecasts full-year profit above estimates on specialty drug strength

U.S. drug distributor Cardinal Health on Tuesday forecast fiscal 2027 profit well above Wall Street expectations after ​topping fourth-quarter profit estimates, driven by sustained demand ‌for specialty drugs.

Reuters • Aug 11, 2026

US Stocks Mixed; Cardinal Health Shares Jump After Q4 Results

Cardinal Health, Inc (NYSE:CAH) shares jumped around 8% after the company posted results for the fourth quarter.

Benzinga • Aug 11, 2026

Cardinal Health Ticks Higher Despite Medical Wholesaler's Mixed Quarter

Cardinal Health stock rose slightly early Tuesday on better-than-expected fiscal fourth-quarter earnings, but sales missed.

Investors Business Daily • Aug 11, 2026

Cardinal Health Q4 Earnings Call Highlights

Cardinal Health NYSE: CAH reported fourth-quarter fiscal 2026 results marked by growth in revenue, operating earnings and adjusted earnings per share, supported by demand in its pharmaceutical and specialty businesses and a one-time tariff-related benefit in its medical products segment.

MarketBeat • Aug 11, 2026

Can Cardinal Health's Strong Earnings Guidance Offset a Mixed Quarter?

Cardinal Health reports mixed quarterly performance across its business segments as earnings get a lift from one-time tariff refunds.

Barrons • Aug 11, 2026

Cardinal Health, Inc. (CAH) Q4 2026 Earnings Call Transcript

Cardinal Health, Inc. (CAH) Q4 2026 Earnings Call Transcript

Seeking Alpha • Aug 11, 2026

Cardinal Health Reports Fourth Quarter and Fiscal Year 2026 Results and Provides Fiscal Year 2027 Guidance

Fourth quarter revenue increased 6% to $63.7 billion Fourth quarter GAAP 1 diluted EPS increased 70% to $1.70 Excluding a one-time positive impact of $0.31 from the recognition of the IEEPA tariff refund, fourth quarter non-GAAP diluted EPS increased 25% to $2.60, with reported fourth quarter non-GAAP diluted EPS increasing 40% to $2.91 For fiscal year 2026, excluding the IEEPA tariff refund recognition, non-GAAP diluted EPS increased 33% to $10.95, with reported non-GAAP diluted EPS increasing 37% to $11.26 Fiscal year 2026 operating cash flow $5.2 billion and adjusted free cash flow $5.0 billion Incremental $350 million share repurchase completed, bringing fiscal year 2026 repurchase total to $1.4 billion, with $5.0 billion incremental repurchase authorization approved by board of directors Cardinal Health provides fiscal year 2027 non-GAAP EPS guidance2 of 13% to 15% growth3 ($12.40 to $12.60), above the Company's long-term EPS guidance DUBLIN, Ohio, Aug. 11, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported fourth quarter fiscal year 2026 revenues of $63.7 billion, an increase of 6% from the fourth quarter of fiscal year 2025. Fourth quarter GAAP operating earnings increased 70% to $729 million and GAAP diluted earnings per share (EPS) increased 70% to $1.70.

PRNewsWire • Aug 11, 2026

Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Cardinal Health, Inc. (NYSE:CAH) will release its fourth quarter earnings report before the opening bell on Tuesday, Aug. 11.

Benzinga • Aug 11, 2026